Polyplex Corporation Limited

rs,

ast, Mumbai- 400 051 - Listing Department, The General Manager BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 SYMBOL: POLYPLEX BSE Scrip Code: 524051 Dear Sir(s), Sub: Regulati

4%

ility Fully Integrated Upstream and Downstream Capabilities Product Breakdown (FY22 Revenues) 4% 4% 5% 6% 11% 16% 54% 34 Years of Operation At the Forefront of Sustainability and Circula

5%

Fully Integrated Upstream and Downstream Capabilities Product Breakdown (FY22 Revenues) 4% 4% 5% 6% 11% 16% 54% 34 Years of Operation At the Forefront of Sustainability and Circular Econ

6%

y Integrated Upstream and Downstream Capabilities Product Breakdown (FY22 Revenues) 4% 4% 5% 6% 11% 16% 54% 34 Years of Operation At the Forefront of Sustainability and Circular Economy

11%

tegrated Upstream and Downstream Capabilities Product Breakdown (FY22 Revenues) 4% 4% 5% 6% 11% 16% 54% 34 Years of Operation At the Forefront of Sustainability and Circular Economy ~2,

16%

ted Upstream and Downstream Capabilities Product Breakdown (FY22 Revenues) 4% 4% 5% 6% 11% 16% 54% 34 Years of Operation At the Forefront of Sustainability and Circular Economy ~2,650 C

54%

Upstream and Downstream Capabilities Product Breakdown (FY22 Revenues) 4% 4% 5% 6% 11% 16% 54% 34 Years of Operation At the Forefront of Sustainability and Circular Economy ~2,650 Custom

100%

ng” process for manufacturing Sarafil rPET film with Post- Consumer Recycled (PCR) content up to 100%. Capacity addition in Thailand & Turkey Ramp up of recent investment for a new post-consumer

22%

s… (Q4 FY 21-22) (FY 21-22) India Rating & Research IND AA- (Positive Outlook) $250mm Revenue# 22% Normalized EBITDA* Margin $54mm Normalized EBITDA* 31% ROCE1 $887mm Revenue# 21% Normalized

31%

AA- (Positive Outlook) $250mm Revenue# 22% Normalized EBITDA* Margin $54mm Normalized EBITDA* 31% ROCE1 $887mm Revenue# 21% Normalized EBITDA* Margin $186mm Normalized EBITDA* 27% ROCE1 …Dri

21%

mm Revenue# 22% Normalized EBITDA* Margin $54mm Normalized EBITDA* 31% ROCE1 $887mm Revenue# 21% Normalized EBITDA* Margin $186mm Normalized EBITDA* 27% ROCE1 …Driven by Strong, Sustainable P

27%

d EBITDA* 31% ROCE1 $887mm Revenue# 21% Normalized EBITDA* Margin $186mm Normalized EBITDA* 27% ROCE1 …Driven by Strong, Sustainable Profitability Widening of the Product Portfolio Operationa

“These are based on certain assumptions as on date and are subject to significant risks and uncertainties, as they could be substantially influenced by several factors which are beyond Company’s control including, but not limited to, fluctuations in foreign exchange rates, changes in key raw material prices, changes in market dynamics, impact of consolidation of subsidiaries and any unexpected production down times due to machinery breakdown, unforeseen delays in project start up etc.”

Factors impacting YoY

1

Factors impacting YoY

▪ Higher Revenue due to rise in sales price on account of higher ▪ Higher volumes supplemented by start up of BOPP line in Indonesia RM cost ▪ Higher Revenue due to rise in sales price on account of higher RM ▪ Higher VA levels resulting in better EBITDA margins cost ▪ In Q4 21-22, there is an unrealized FX gain of INR 30.79 crores ($ ▪ Higher VA resulting in better per unit EBITDA margin 4.09 million) as against unrealized FX gain of INR 65.39 crores ($ ▪ Favorable impact of FX fluctuation on change in stock on account of 8.73 million) in Q3 21-22 on account of restatement of foreign consolidation. In Q4 22, there is a gain of INR 13.68 crores ($1.82 currency long term loans million) as against a loss of INR 14.36 crores ($1.93 million) in Q4 21 9 FY 21-22 Performance Snapshot Sales Volume (All Films) 3,22,785 MT Sales Revenue 6,607 INR Crores ($ 887 million) Normalized EBITDA 1,382 INR Crores ($ 186 million) PAT (Before Minority) 965 INR Crores ($ 130 million) EPS 181.19 INR/Share Yo